APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast – Biotech Investments
EQS-News: APONTIS PHARMA AG / Key word(s): Change in Forecast/Alliance APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and